New Brunswick, NJ, October 1, 2001 — New Jersey’s pharmaceutical companies support New Jersey Senate Concurrent Resolution 116, which calls for Congress to enact legislation to provide prescription drug coverage for Medicare recipients without penalizing states, such as New Jersey, that have their own pharmaceutical assistance programs for their elderly residents.
“New Jersey has led the nation with its Prescription Assistance for the Aged and Disabled (PAAD) program, and with Senior Gold,” said Bob Franks, president of the HealthCare Institute of New Jersey, an association for the state’s pharmaceutical and medical technology companies.
“This resolution expresses the importance of passing legislation that would increase access to prescription pharmaceuticals for seniors, without penalizing New Jersey for the strides we’ve already made,” Franks said. “We support his concept, and this resolution.”
The HealthCare Institute of New Jersey is an association of 17 pharmaceutical and medical technology companies with their U.S. or global headquarters in New Jersey.